Navigating Oral Therapy in Breast Cancer: Practice Strategies to Promote Medication Adherence

Breast Cancer
Video Library
Robert J. Ferguson, PhD
Clinical Psychologist and Assistant Professor of Medicine
Division of Hematology/Oncology
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center
Pittsburgh, PA
Madelaine C. Kuiper, NP
Hematology Oncology
UCLA Health System
Santa Monica, CA
Maryam Lustberg, MD, MPH
Associate Professor of Internal Medicine (Medical Oncology)
Director, Center for Breast Cancer
Chief, Breast Medical Oncology
Yale Cancer Center
New Haven, CT

Featuring:

The Academy of Oncology Nurse & Patient Navigators (AONN+) and Eli Lilly and Company Medical Affairs are pleased to present a live webinar designed to facilitate conversations with patients regarding adherence to breast cancer treatments. Attendees will have an opportunity to participate in a live Q&A following the presentation.

Attendees will be able to:

  • Describe the role of the nurse navigator within the multidisciplinary team in supporting medication adherence & persistence
  • Identify modifiable factors associated with medication non-adherence amenable to nursing intervention
  • Apply evidence-based psychological approaches to support medication adherence in clinical practice
  • Construct strategies to improve adherence & persistence in practice using a breast cancer case study

Speakers

Robert J. Ferguson, PhD
Clinical Psychologist and Assistant Professor of Medicine
Division of Hematology/Oncology
University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center
Pittsburgh, PA

Madelaine C. Kuiper, NP
Hematology Oncology
UCLA Health System
Santa Monica, CA

Maryam Lustberg, MD, MPH
Associate Professor of Internal Medicine (Medical Oncology)
Director, Center for Breast Cancer
Chief, Breast Medical Oncology
Yale Cancer Center
New Haven, CT

VV-MED-128153 09/2022 CPS REG1058951
© 2022 Lilly USA, LLC. All rights reserved.

Related Items

Supporting Young Patients With Breast Cancer
By Zeena Nackerdien, PhD
Breast Cancer
December 2025 Vol 16, No 12
Explore the unique challenges faced by young patients with breast cancer and learn how innovative navigation programs are bridging gaps in care and empowering patients to thrive.
Identification and Treatment of Patients With Hormone Receptor–Positive, HER2-Negative Early Breast Cancer at High Risk of Recurrence: monarchE Study Long-Term Outcomes
Clinical Trials, HR+/HER2− Breast Cancer, Breast Cancer
Special Issues and Supplements
We are pleased to announce the release of our next issue of Clinical Trials to Clinical Practice. This article provides expert commentary from Joyce A. O’Shaughnessy, MD, on the use of endocrine therapy with or without adjuvant abemaciclib for patients with high-risk, hormone receptor (HR)-positive, HER2-negative early breast cancer.
Navigator Guide: Walking With a Patient Down the Early Breast Cancer Path
Breast Cancer, Resources, HR+/HER2− Breast Cancer
Resources
The Navigator Guide: Walking With a Patient Down the Early Breast Cancer Path is a resource that oncology nurses and navigators can use to assist patients and caregivers in the fight against early-stage breast cancer. Oncology nurses and navigators guide patients through their treatment journey from time of diagnosis into survivorship, providing education, resources, and support.
Journal of Oncology Navigation & Survivorship

Connect with Us

 
 

Contact Us | Editorial Board

Amplity

© Amplity, Inc. All rights reserved.

JONS

Subscribe Today!

To sign up for our print publication or e-newsletter, please enter your contact information below.

I'd like to receive:

  • First Name *
    Last Name *
     
    Profession or Role
    Primary Specialty or Disease State
    Country

Back to Top

Amplity © Amplity, Inc. All rights reserved.

We Value Your Feedback! Tell Us How You Consume Content

Your feedback will help us tailor our content to better meet your needs and preferences.

*First Name
*Last Name
*Email
*What's your favorite format for experiencing our content?